Lihit Lab.,Inc.
Tokyo Stock ExchangeTotal Valuation
Lihit Lab.,Inc. carries a market capitalization of 3.72B, placing it among publicly traded companies globally. Its enterprise value stands at 2.91B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.72B |
| Enterprise Value | 2.91B |
Share Statistics
Lihit Lab.,Inc. currently has 3.39M shares outstanding.
| Shares Outstanding | 3.39M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 0.43, and the price-to-book ratio stands at 0.47.
| PE Ratio | N/A |
| PS Ratio | 0.43 |
| PB Ratio | 0.47 |
| P/TBV Ratio | 0.38 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
| EV / Sales | 0.32 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | 608.36 |
Financial Position
Lihit Lab.,Inc. maintains a current ratio of 5.01, meaning it holds 5.0x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 5.79, indicating elevated leverage, while an interest coverage ratio of -16.52 demonstrates limited ability to service its debt obligations.
| Current Ratio | 5.01 |
| Quick Ratio | 1.36 |
| Debt / Equity | 5.79 |
| Debt / EBITDA | -5.44 |
| Interest Coverage | -16.52 |
Financial Efficiency
| Return on Equity (ROE) | -0.57 |
| Return on Assets (ROA) | -0.36 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -0.22 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 2.57 |
Taxes
Over the trailing twelve months, Lihit Lab.,Inc. has paid -18.09M in income taxes, reflecting an effective tax rate of 35.94.
| Income Tax | -18.09M |
| Effective Tax Rate | 35.94 |
Stock Price Statistics
Lihit Lab.,Inc.'s stock has declined approximately -5.19481% over the past 52 weeks. The 50-day moving average sits at 1,114.28, while the 200-day moving average is 1,194.85.
| Beta (5Y) | N/A |
| 52-Week Price Change | -5.19481% |
| 50-Day Moving Average | 1,114.28 |
| 200-Day Moving Average | 1,194.85 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Lihit Lab.,Inc. generated 9.03B in revenue and converted that into -47.10M in net income, yielding earnings per share of -13.88. EBITDA reached -109.32M, while operating income came in at -109.32M.
| Revenue | 9.03B |
| Gross Profit | 2.72B |
| Operating Income | -109.32M |
| Pretax Income | -65.19M |
| Net Income | -47.10M |
| EBITDA | -109.32M |
| EBIT | -109.32M |
| Earnings Per Share (EPS) | -13.88 |
Balance Sheet
Lihit Lab.,Inc. holds 1.53B in cash and equivalents against 594.50M in total debt, resulting in a net debt position of -932.66M. Total book value stands at 8.13B, with working capital of 4.52B providing operational flexibility.
| Cash & Cash Equivalents | 1.53B |
| Total Debt | 594.50M |
| Net Debt | -932.66M |
| Equity (Book Value) | 8.13B |
| Book Value Per Share | 2,396.41 |
| Working Capital | 4.52B |
Margins
Lihit Lab.,Inc. operates with a gross margin of 30.12, reflecting its pricing power and cost economics. The operating margin of -1.21 and net profit margin of -0.52 provide insight into operational efficiency.
| Gross Margin | 30.12 |
| Operating Margin | -1.21 |
| Pretax Margin | -0.72 |
| Profit Margin | -0.52 |
| EBITDA Margin | -1.21 |
Stock Splits
Lihit Lab.,Inc.'s most recent stock split took place on November 29, 2021 with a 1:2 split ratio.
| Last Split Date | 11/29/2021 |
| Split Ratio | 1:2 |
Scores
Lihit Lab.,Inc. posts an Altman Z-Score of 2.61, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 2.61 |